Dexpramipexole

Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma

Phase 3 Extension Study of Dexpramipexole in ALS

Phase 3 Study of Dexpramipexole in ALS

Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia

Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)

Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects

Dexpramipexole SAD/MAD Study

Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study